港股異動 | 移卡(9923.HK)大漲逾12% 本月股價已翻倍 女股神上週五再度入場掃貨
格隆匯1月25日丨移卡(9923.HK)飆升逾12%,暫錄4連漲,報77.55港元,今早高見79.15港元創歷史新高,本月以來股價已經翻倍,成交額5.57億港元,最新總市值346.65億港元。有“女股神”之稱的凱瑟琳.伍德旗下主打金融科技創新的基金ARKF,繼上週四增持107.6萬股移卡後,上週五進一步入場掃貨,涉及11.68萬股,使得持股量由上週四的626.4萬股,增至上週五的638.08萬股,相當於ARKF持倉佔比2.11%,為ARKF第18大持股(上週四為第25大持股)。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.